LSE : 0HI3.L

Arrowhead Pharmaceuticals, Inc. — News

$85.88 USD

-$1.79 (-2.04%)

Volume
573
Average Volume
1.78K
Market Capitalization
$11.95B
P/E Ratio
-40.00
Dividend Yield
0.00%
Price Target
Year High
$88.98
Year Low
$20.75
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$6.23
Source Headline

Get 0HI3.L Insider Trade Alerts

0HI3.L Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

0HI3.L Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-07-23 Piper Sandler Maintain Overweight Overweight
2026-07-23 Morgan Stanley Maintain Overweight Overweight
2026-07-22 Chardan Capital Maintain Buy Buy
2026-07-17 JP Morgan Maintain Overweight Overweight
2026-07-01 HC Wainwright & Co. Maintain Buy Buy
2026-06-30 Chardan Capital Maintain Buy Buy
2026-06-17 Leerink Partners Maintain Market Perform Market Perform
2026-05-13 Bernstein Maintain Market Perform Market Perform
2026-05-08 RBC Capital Maintain Outperform Outperform
2026-04-21 Morgan Stanley Upgrade Equal Weight Overweight
2026-03-25 HC Wainwright & Co. Maintain Buy Buy
2026-02-10 HC Wainwright & Co. Maintain Buy Buy
2026-01-22 B. Riley Securities Maintain Buy Buy
2026-01-21 HC Wainwright & Co. Maintain Buy Buy
2026-01-13 Piper Sandler Maintain Overweight Overweight
2026-01-07 Chardan Capital Maintain Buy Buy
2026-01-07 Morgan Stanley Maintain Equal Weight Equal Weight
2026-01-07 Goldman Sachs Maintain Neutral Neutral